These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

79 related items for PubMed ID: 537889

  • 1. [Peritoneal dialysis and amikacin].
    Humbert G, Leroy J, Moirot E, Leroy A.
    Nouv Presse Med; 1979 Oct 31; 8(42):3430-1. PubMed ID: 537889
    [No Abstract] [Full Text] [Related]

  • 2. The effect of peritoneal dialysis of the pharmacokinetics of amikacin.
    Matzke GR, Salem N, Bockbrader H, Blevins R.
    Proc Clin Dial Transplant Forum; 1980 Oct 31; 10():302-4. PubMed ID: 7346850
    [No Abstract] [Full Text] [Related]

  • 3. [Pharmacokinetics of amikacin in subjects with normal renal function, in chronic renal failure and during hemodialysis].
    Oksenhendler G, Leroy A, Fillastre JP, Humbert G.
    Nouv Presse Med; 1979 Oct 31; 8(42):3426-9. PubMed ID: 537888
    [No Abstract] [Full Text] [Related]

  • 4. [Peritoneal transfer of amikacin: its use in peritoneal dialysis. Preliminary study].
    Slingeneyer A, Liendo-Liendo C, Despaux E, Balmayer B, Perez C, Mion C.
    Nouv Presse Med; 1979 Oct 31; 8(42):3432-5. PubMed ID: 537890
    [No Abstract] [Full Text] [Related]

  • 5. Influence of type of dialyzer on the pharmacokinetics of amikacin.
    Lanao JM, Dominguez-Gil A, Tabernero JM, Macias JF.
    Int J Clin Pharmacol Ther Toxicol; 1983 Apr 31; 21(4):197-202. PubMed ID: 6862725
    [Abstract] [Full Text] [Related]

  • 6. Pharmacokinetics of amikacin (BB-K8) in patients undergoing hemodialysis.
    Lanao JM, Dominguez-Gil A, Tabernero JM, Sanchez Tomero JA.
    Int J Clin Pharmacol Biopharm; 1979 Aug 31; 17(8):357-60. PubMed ID: 489203
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Pharmacokinetics of lividomycin, aminkacin and sisomicin in patients with chronic renal insufficiency].
    Leroy A, Oksenhendler G, Fillastre JP, Humbert G.
    J Urol Nephrol (Paris); 1977 Sep 31; 83(9):738-41. PubMed ID: 243544
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Myoinositol level in the serum and urine of children with renal failure during conservative treatment and treatment with peritoneal dialysis].
    Bednorz R.
    Pol Tyg Lek; 1986 Apr 07; 41(14):440-3. PubMed ID: 3725687
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Pharmacokinetics of amikacin in patients with impaired renal function.
    McHenry MC, Wagner JG, Hall PM, Vidt DG, Gavan TL.
    J Infect Dis; 1976 Nov 07; 134 SUPPL():S343-8. PubMed ID: 993627
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Disposition kinetics of amikacin in patients with renal impairment after intramuscular administration.
    Lanao JM, Dominguez-Gil A, Tabernero JM, Molina HD.
    Int J Clin Pharmacol Ther Toxicol; 1982 Jun 07; 20(6):271-5. PubMed ID: 7107075
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.